Frazier Life Sciences Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138M | Buy |
|
|||||
|
2025
Q1 | $137M | Hold |
|
|||||
|
2024
Q4 | $122M | Hold |
|
|||||
|
2024
Q3 | $81.7M | Hold |
|
|||||
|
2024
Q2 | $81.7M | Hold |
|
|||||
|
2024
Q1 | $87.1M | Buy |
|
|||||
|
2023
Q4 | $28.3M | Buy |
|
|||||
|
2023
Q3 | $46.1M | Hold |
|
|||||
|
2023
Q2 | $82.8M | Hold |
|
|||||
|
2023
Q1 | $95.5M | Hold |
|
|||||
|
2022
Q4 | $129M | Hold |
|
|||||
|
2022
Q3 | $166M | Buy |
|
|||||
|
2022
Q2 | $180M | Hold |
|
|||||
|
2022
Q1 | $162M | Buy |
|